Yuyu Pharma (XKRX:000220) Debt-to-Asset : 0.20 (As of Dec. 2023)

View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma Debt-to-Asset?

Yuyu Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩25,386 Mil. Yuyu Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩14,021 Mil. Yuyu Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was ₩198,214 Mil. Yuyu Pharma's debt to asset for the quarter that ended in Dec. 2023 was 0.20.

Yuyu Pharma Debt-to-Asset Historical Data

The historical data trend for Yuyu Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma Debt-to-Asset Chart

Yuyu Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.20

0.13

0.20

Yuyu Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.20	0.21	0.23	0.22	0.20

Competitive Comparison of Yuyu Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Yuyu Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yuyu Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuyu Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Yuyu Pharma's Debt-to-Asset falls into.

Yuyu Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Yuyu Pharma's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(25386.189	+	14020.963)	/	198213.527
	=	0.20

Yuyu Pharma's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(25386.189	+	14020.963)	/	198213.527
	=	0.20

Yuyu Pharma (XKRX:000220) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Yuyu Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Yuyu Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuyu Pharma (XKRX:000220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » Debt-to-Asset

Traded in Other Exchanges

000227.PFD:Korea 000225.PFD:Korea

Address

197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR

Website

http://www.yuyu.co.kr

Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines